Company Filing History:
Years Active: 2022
Title: Matthew William Haave: Innovator in Drug Delivery Technology
Introduction
Matthew William Haave is a notable inventor based in Seattle, WA, who has made significant contributions to the field of drug delivery devices. His innovative work focuses on enhancing the functionality and efficiency of these devices, particularly through the development of advanced sensing technologies.
Latest Patents
Haave holds a patent for a "Rotary dosage sensing module for and in a disposable pen drug delivery device." This invention features a dosage sensing module that includes a power source unit, a processor unit, and a dosage sensor unit. The first sensor part is designed to remain fixed during dose expelling, utilizing a flexible printed circuit board sheet with a pattern of individual electrical conductive sensor areas. The second sensor part is attached to the piston rod, allowing it to follow the rotation during dose expelling. This innovative design enables the generation of electrical signals indicative of the relative rotational position between the two sensor parts, enhancing the precision of drug delivery.
Career Highlights
Matthew William Haave is currently employed at Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His role at the company allows him to apply his expertise in developing cutting-edge drug delivery solutions.
Collaborations
Haave has collaborated with notable colleagues, including Carsten Schau Andersen and Dave Szakelyhidi, who have contributed to his innovative projects and advancements in drug delivery technology.
Conclusion
Matthew William Haave's contributions to the field of drug delivery devices exemplify the importance of innovation in healthcare technology. His patented work continues to influence the development of more effective and user-friendly drug delivery systems.